Amrutanjan Health Care Limited · NSE:AMRUTANJAN
Amrutanjan Health Care — Q4 FY20 Earnings Presentation
17 slides from Amrutanjan Health Care's earnings presentation, Jun 18, 2020
Slide 1: Stock exchange cover letter for investor presentation
AHCL/ SE/ 13 /2020-21 June 18 2020 The National Stock Exchange of BSE Limited IndiaLimited Department of Corporate Services “Exchange Plaza”, C-1, Block G 1st Floor, Bandra-Kurla Complex, Bandra (E) PJ. Towers, Dalal Street, Mumbai 400 051 Mumbai 400 001 Symbol : AMRUTANJAN Scrip Code: 590006 Dear S
Slide 2: Investor Presentation – Quarter & Year Ended 31st March 2020
Amrutanjan Health Care Limited Investor Presentation – Quarter & Year Ended 31st March 2020 Date: 18th June 2020
Slide 3: Contents
Contents a. Business update b. FY20 Performance c. Q4 FY20 Performance d. Way Forward Investor Presentation | Quarter & Year Ended 31st March 2020 2
Slide 4: Business Update
Business Update Investor Presentation | Quarter & Year Ended 31st March 2020 3
Slide 5: Business Update – COVID
Business Update – COVID SALES LOST DUE FY20 SALES IF Particulars FY20 FY19 GROWTH TO COVID NO COVID GROWTH Gross Sales (Rs. In Crores) 288.92 281.31 7.61 33.00 321.92 40.61 Growth % 2.71% Growth % (if no COVID) 14.44% • Due to COVID we have lost the revenue of INR 33 cr in the month of March20. The
Slide 6: Relaunched "NOGERMS" Hand Sanitizer
Relaunched “NOGERMS” Hand Sanitizer Investor Presentation | Quarter & Year Ended 31st March 2020 5
Slide 7: FY20 Performance
FY20 Performance Investor Presentation | Quarter & Year Ended 31st March 2020 6
Slide 8: Financials – FY20
Financials – FY20 (Rs. in Crores) Gross Sales Profit Before Tax Profit After Tax 288.92 34.68 25.08 281.31 34.45 24.51 FY20 FY19 FY20 FY19 FY20 FY19 Growth: 2.71% Growth: - 0.66% Growth: 2.33% Note: Profit Before & After Tax includes Profit / Loss from discontinued operations for last year. Investor
Slide 9: Financials – FY20 – OTC Division
Financials – FY20 – OTC Division (Rs. in Crores) Gross Sales - OTC 266.05 Notes: 255.93 • Key raw material prices including FY20 FY19 Menthol are lower when compared to FY19. Growth: 3.95% • Gross Margin has improved by 260 Gross Sales - Comfy basis points when compared to last year. 39.99 35.31 • A
Slide 10: Financials – FY20 – Beverage Division
Financials – FY20 – Beverage Division (Rs. in Crores) Gross Sales - Beverages 23.44 Notes: 20.45 • Loss from this business are coming down for the last 2 FY20 FY19 years. Growth: -12.76% • Advertisement spend is Rs.0.81 cr for FY20 against Rs.3.30 cr Gross Sales - Electro Plus for FY19. 8.00 • Busin
Slide 11: Key Financial Ratios
Key Financial Ratios Return on Capital Employed % Operating Profit Margin (%) 22.95% 13.92% 20.85% 13.26% FY20 FY19 FY20 FY19 Debtors Turnover Ratio Inventory Turnover Ratio 8.80 20.31 13.66 8.32 FY20 FY19 FY20 FY19 Investor Presentation | Quarter & Year Ended 31st March 2020 10
Slide 12: Q4 FY20 Performance
Q4 FY20 Performance Investor Presentation | Quarter & Year Ended 31st March 2020 11
Slide 13: Financials – Q4 FY20
Financials – Q4 FY20 (Rs. in Crores) Gross Sales Profit Before Tax Profit After Tax 94.88 14.27 66.20 20.25 7.89 10.64 Q4 FY20 Q4 FY19 Q4 FY20 Q4 FY19 Q4 FY20 Q4 FY19 Growth: -30.23% Growth: -47.46% Growth: -44.71% Note: Profit Before & After Tax includes Profit / Loss from discontinued operations f
Slide 14: Financials – Q4 FY20
Financials – Q4 FY20 (Rs. in Crores) Gross Sales - OTC Gross Sales - Comfy Gross Sales - Beverages 84.17 11.49 10.15 59.30 7.43 6.41 Q4 FY20 Q4 FY19 Q4 FY20 Q4 FY19 Q4 FY20 Q4 FY19 Growth: -29.55% Growth: -35.34% Growth: -36.85% Investor Presentation | Quarter & Year Ended 31st March 2020 13
Slide 15: Way Forward
Way Forward Investor Presentation | Quarter & Year Ended 31st March 2020 14
Slide 16: Way Forward
Way Forward • Focus remains on expansion of distribution • Costs control • Expanding E-Commerce business Investor Presentation | Quarter & Year Ended 31st March 2020 15
Slide 17: Investor Presentation | Quarter & Year Ended 31st March 2020
Investor Presentation | Quarter & Year Ended 31st March 2020 16
Amrutanjan Health Care — Q4 FY20 Earnings Presentation on 6ix